Cargando…
MLN2238 exerts its anti-tumor effects via regulating ROS/JNK/mitochondrial signaling pathways in intrahepatic cholangiocarcinoma
Background: Intrahepatic Cholangiocarcinoma (iCCA) is a highly malignant tumor with limited treatment options that contributes largely to cancer-related deaths worldwide. Compared with traditional transcriptomic analysis, single-cell RNA sequencing (scRNA-seq) is emerging as a more advanced and popu...
Autores principales: | Xu, Hao, Xu, Guangyu, Xu, Qianhui, Xu, Chang, Zhou, Xiaohu, Bai, Yang, Yin, Lu, Ding, Yuan, Wang, Weilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659592/ https://www.ncbi.nlm.nih.gov/pubmed/36386204 http://dx.doi.org/10.3389/fphar.2022.1040847 |
Ejemplares similares
-
The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma
por: Suarez, Lorena P., et al.
Publicado: (2016) -
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells
por: Augello, Giuseppa, et al.
Publicado: (2018) -
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
por: Manieri, Elisa, et al.
Publicado: (2020) -
Creatinine accelerates APAP-induced liver damage by increasing oxidative stress through ROS/JNK signaling pathway
por: Liu, Fang, et al.
Publicado: (2022) -
Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma
por: Lee, Kyung-Hun, et al.
Publicado: (2015)